Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Urologic Neoplasms 10. August 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 9031  Previews Next
   
   Articles 1 - 20 / 180603  
   
Renal outcomes and compensatory hypertrophy in survivors of unilateral non-syndromic Wilms tumour: a single-centre cross-sectional study from a tertiary-care institution in India.
Pediatr Surg Int
Potturu M, Sehgal M, Sinha A, Jana M, Rangarajan K, Datta SK, Kumar R, Nilima N, Yadav DK, Goel P, Agarwala S, Dhua AK, Srinivas M, Gali D, Jain V.
PMID: 42573811 [PubMed - indexed for MEDLINE]


Multimodal artificial intelligence for prostate cancer imaging: workflow-relevant fusion of mpMRI, PSMA PET, ultrasound, and clinical data for diagnosis, local staging, and treatment personalization.
Abdom Radiol (NY)
Doniyor T, Jasur R, Gulnihol S, Dilorom S, Aliev S, Kenjaev Y.
PMID: 42573772 [PubMed - as supplied by publisher]


ASO Visual Abstract: Risk-adapted use of adjuvant systemic therapy after nephrectomy for renal cell carcinoma: a population-based study in the post-approval era.
Ann Surg Oncol
Filzmayer M, Petix M, Quarta L, Orlandi F, Goyal JA, Carmignani L, Briganti A, Micali S, Shariat SF, Wenzel M, Heß-Busch Y, Humke C, Saad F, Chun FK, Karakiewicz PI.
PMID: 42573667 [PubMed - as supplied by publisher]


Impact of structured reporting on interpretability of PSMA PET/CT in prostate cancer staging-towards standardised clinical implementation.
Eur Radiol Exp
Biechele G, Schnitzer M, Göbel R, Bauer N, Fouladgar ST, Herr F, Zaganjori M, Holzgreve A, Klimek K, Werner R, Cyran C, Ricke J, Rübenthaler J, Geyer T.
PMID: 42573660 [PubMed - indexed for MEDLINE]


Epidemiology and Overall Survival of De Novo and Transformed Neuroendocrine Prostate Cancer: A Two-Nation Population-Based Study of 1,465 Patients from the United States and England.
Endocr Relat Cancer
Choi S, Mortagy M, Tan KS, White BE, Paisey S, Abdelhameed A, Rous B, Ramage J.
PMID: 42573114 [PubMed - as supplied by publisher]


How low do you need to go? Association between various prostate-specific antigen response measures and clinical outcomes in metastatic castration-sensitive prostate cancer in the Veterans Health Administration data.
Cancer
Freedland SJ, Gao W, Touya M, Yang H, Russell D, Chen J, Chen G, Ivanova JI.
PMID: 42572469 [PubMed - indexed for MEDLINE]


Effect of Implementing Population-Based Prostate-Specific Antigen Screening on Testing Rates and Prostate Cancer Overdiagnosis in England: A Statistical Modelling Study.
Int J Cancer
Vickers AJ, Kasivisvanathan V, Brentnall AR.
PMID: 42572363 [PubMed - as supplied by publisher]


Thinking, Feeling, Choosing: How Affect Is Reflected in Prostate Cancer Treatment Decision Making-A Qualitative Study.
Psychooncology
Gong R, Alfonso N, Mossel AMV, Ordosgoitia MN, Montano JM, Jacques A Jr, Traeger L, Heller AS, Antoni MH, Crane TE, Gonzalgo ML, Mahal BA, Nahar B, Ritch C, Parekh DJ, Punnen S, Penedo FJ.
PMID: 42571713 [PubMed - indexed for MEDLINE]


Ten tips for kidney biopsy in cancer patients.
Clin Kidney J
Simeoni M, Ollero M, Garcia-Carro C, Bagnis C, Kousios A, van den Berg G, Soler MJ, Tesar V, Malyszko J.
PMID: 42571592 [PubMed]


Prostate Cancer Mortality in Men not Attending a Population-based Screening Program: The 'Good', the 'Bad', and the 'Ugly' After 20-yr Follow-up in the European Randomised study of Screening for Prostate Cancer.
Eur Urol Open Sci
Leenen RCA, Mulder EFH, Remmers S, de Vos II, Talala K, Hugosson J, Arnsrud-Godtman R, Hond ED, Villers A, Pionas G, Llane L, Lujan M, Gorini G, Puliti D, Kwiatkowski M, Wyler S, Bangma C, Schroder FH, Auvinen A, Roobol MJ, ERSPC Study Group.
PMID: 42571431 [PubMed]


A Pathology-Based Model for Postoperative Recurrence or Metastasis Prediction and Adjuvant Immunotherapy Implications of Clear-Cell Renal Cell Carcinoma: A Multicenter, Retrospective Study.
Ann Surg Oncol
Zhu Y, Ge L, Liu Z, Sun J, Wang X, Chu C, Zhao Z, Zhu Z, Shen H, Shi J, Liu G, Ji C, Zhang Q, Gan W, Zhang S, Jiang B, Guo H.
PMID: 42570984 [PubMed - as supplied by publisher]


Role of Cutibacterium acnes and Bacteroides fragilis in Prostate Cancer: a Turkish Population-Based Case-Control Study.
Clin Lab
Tokuc E, Gurses I, Aferin U, Ercili B, Gurbuz A, Erozenci NA, Bakar MT, Aksu O, Demirci M, Kurt Z, Ozturk-Bakar Y, Ceylan-Kilincarslan A, Ziyad MA, Turk S, Kocazeybek BS, Bahar-Tokman H.
PMID: 42570665 [PubMed - indexed for MEDLINE]


Prediction models for adverse events from prostate cancer curative radiotherapy: a systematic review of methodological quality.
Transl Oncol
Oliveira CC, Jongen CAM, Mikoli, Incrocci L, Lingsma HF, Roobol MJ, Korfage I, Heemsbergen WD, van Klaveren D, 4D PICTURE consortium.
PMID: 42570550 [PubMed - as supplied by publisher]


PSMA PET in Prostate Cancer: Clinical Value, Access Challenges, and Priorities for Implementation.
Eur Urol Oncol
Peyrottes A, Turpin L, Hernández LF, Rivas JG, Rouprêt M.
PMID: 42552166 [PubMed - as supplied by publisher]


Re: Emanuele Messina, Antonella Borrelli, Alessandro Sciarra, et al. Primary Noncontrast Magnetic Resonance Imaging for Prostate Cancer Screening: A Randomized Clinical Trial (PROSA). Eur Urol 2025;89:246-57.
Eur Urol
Luca S, Ferrando L, Porpiglia F.
PMID: 42552153 [PubMed - as supplied by publisher]


Beyond the Trial: Can Audit and Feedback Produce Lasting Improvements in Transurethral Resection of Bladder Tumor Quality?
Fr J Urol
Mercier J, de la Taille A, Vordos D, Duquesne I.
PMID: 42551555 [PubMed - as supplied by publisher]


Mortality in Medicare-aged Men with Metastatic Prostate Cancer After the Introduction of Androgen Receptor Pathway Inhibitors: A Population-Based Study.
Urology
Kim IE Jr, Hartman R, Gandhi K, Nikita N, Banks J, Kelly WK, Keith SW, Kim IY, Lu-Yao G.
PMID: 42551541 [PubMed - as supplied by publisher]


Artificial intelligence in prostate cancer diagnosis and management: state-of-the-art approaches and emerging innovations.
Clin Adv Hematol Oncol
Lee MS, Shi CT, Kim TH, Morales Martinez GA, Vasdev R, Waddle M, Takahashi N, Boorjian SA, Khanna A.
PMID: 42550814 [PubMed - indexed for MEDLINE]


Efficacy, safety, and quality of life outcomes of [(177)Lu] Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer: a GRADE-assessed systematic review, meta-analysis and trial sequential analysis.
Int Urol Nephrol
Mubarika M, Maaz M, Muhammad A, Emmama S, Mazhar Z, Khalid M, Kumari J, Alamin MH, Ayalew BD, Noor H, Hassan M, Khawar M, Sadiq MH, Syed GMS, Evangelista L, Bomanji J.
PMID: 42570199 [PubMed - as supplied by publisher]


Comparison of postoperative and early oncological outcomes of open versus robotic radical cystectomy.
J Robot Surg
Eleftheriou C, Zhao Y, Lami M, Boaz RJ, Moftah A, Jurdon K, Khan A, Gibbons N, Hellawell G, Bolton E, Heer R.
PMID: 42570123 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 180603    Page 1 of 9031  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1